A phase II evaluation of a 3-drug combination of cyclophosphamide, doxorubicin and 5-fluorouracil and of 5-fluorouracil in patients with advanced bladder carcinoma or stage D prostatic carcinoma

Journal of Urology

Volumn 125, Issue 2, 1981, Pages 191-195

  Smalley, R V ^a   Bartolucci, A A ^a   Hemstreet, G ^a   Hester, M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADVERSE DRUG REACTION; ALOPECIA; BLADDER; BLADDER CANCER; BLADDER CARCINOMA; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG COMPARISON; HEART; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE GENITAL SYSTEM; PROSTATE CANCER; PROSTATE CARCINOMA; RANDOMIZED CONTROLLED TRIAL; THERAPY; VOMITING;

EID: 0019450418     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)54961-7     Document Type: Article

References (23)

1. deKernion J.B. The chemotherapy of advanced bladder cancer Cancer Res. 37 1977 2771
2. Scott W.W. Gibbons R.P. Johnson D.E. Prout G.R. Schmidt J.D. Saroff J. Murphy G.P. The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate J. Urol. 116 1976 211
3. DeWys W.D. Begg C.G. Comparison of adriamycin (adria) and 5-fluorouracil (5 FU) in advanced prostatic cancer Abstract. Proc. Amer. Ass. Cancer Res. 19 1978 331
4. Merrin C. Etra W. Wajsman Z. Baumgartner G. Murphy G.P. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin J. Urol. 115 1976 86
5. Chlebowski R.T. Hestorff R. Sardoff L. Weiner J. Bateman J.R. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial Cancer 42 1978 2546
6. Doe R.P. Seal U.S. Acid phosphatase in urology Surg. Clin. N. Amer. 45 1965 1455
7. Smalley R.V. Carpenter J. Bartolucci A. Vogel C. Krauss S. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group Project Cancer 40 1977 625
8. Schmidt J.D. Gibbons R.P. Johnson D.E. Prout G.R. Scott W.W. Murphy G.P. Chemotherapy of advanced prostatic cancer. Evaluation of response parameters Urology 7 1976 602
9. Gehan E.A. A generalized Wilcoxon test for comparing arbitrarily singly censored samples Biometrika 52 1965 203
10. Merrin C. Cartagena R. Wajsman Z. Baumgartner G. Murphy G.P. Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin J. Urol. 114 1975 884
11. Weinstein S. Schmidt J. Doxorubicin chemotherapy in advanced transitional cell carcinoma Urology 8 1976 336
12. Yagoda A. Future implications of phase 2 chemotherapy trials in ninety-five patients with measurable advanced bladder cancer Cancer Res. 37 1977 2775
13. Cross R.J. Glashan R.W. Humphrey C.S. Robinson M.R.G. Smith P.H. Williams R.E. Treatment of advanced bladder cancer with adriamycin and 5-fluorouracil Brit. J. Urol. 48 1976 609
14. Yagoda A. Watson R.C. Gonzalez-Vitale J.C. Grabstald H. Whitmore W.F. Cis-dichlorodiammineplatinum (II) in advanced bladder cancer Cancer Treat. Rep. 60 1976 917
15. Merrin C. Treatment of advanced bladder cancer with cis-diamminedichloroplatinum (II NSC 119875): a pilot study J. Urol. 119 1978 493
16. Soloway M.S. Cis-diamminedichloroplatinum II in advanced urothelial cancer J. Urol. 120 1978 716
17. Sternberg J.J. Bracken R.B. Handel P.B. Johnson D.E. Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report J.A.M.A. 238 1977 2282
18. Williams S.D. Rohn R.H. Donohue J.P. Einhorn L.H. Chemotherapy of bladder cancer with cis-diamminedichloroplatinum (DDP), adriamycin (ADR) and 5 fluorouracil (5FU) Abstract. Proc. Amer. Ass. Cancer Res. 19 1978 316
19. Troner, M.B., Hemstreet, G.: Cyclophosphamide, adriamycin and platinum (II) (CAP) in the treatment of urothelial malignancy: a pilot study of the Southeastern Cancer Study Group. Cancer Treat. Rep., in press 1980.
20. Schmidt J.D. Scott W.W. Gibbons R.P. Johnson D.E. Prout G.R. Jr. Loening S.A. Soloway M.S. Chu T.M. Gaeta J.F. Slack N.H. Saroff J. Murphy G.P. Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate J. Urol. 121 1979 185
21. Merrin C. Treatment of advanced carcinoma of the prostate (stage D) with infusion of cis-diamminedichloroplatinum (II NSC 119875): a pilot study J. Urol. 119 1978 522
22. Kane R.D. Stocks L.H. Paulson D.F. Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report J. Urol. 117 1977 467
23. Smalley, R.V., Bartolucci, A., Hemstreet, G.: The correlation of response criteria with survival in patients with carcinoma of the prostate treated with cytotoxic chemotherapy. Unpublished data.